
DOI . ORG {
}
Title[redir]:
Survivin โ biology and potential as a therapeutic target in onco | OTT
Description:
Survivin – biology and potential as a therapeutic target in oncology Chun Hei Antonio Cheung,1,2 Chien-Chang Huang,3 Fang-Ying Tsai,4 Jane Ying-Chieh Lee,1 Siao Muk Cheng,2 Yung-Chieh Chang,1 Yi-Chun Huang,1 Shang-Hung Chen,5 Jang-Yang Chang3,6 1Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, 2Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, 3National Institute of Cancer Research, National Health Research Institutes, Tainan, 4South East Asian Health Education Center in Taiwan (SEAHECT), College of Medicine, National Cheng Kung University, Tainan, 5Division of Hematology and Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Liouying, Tainan, 6Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, Republic of China Abstract: Survivin is a member of the inhibitor-of-apoptosis proteins (IAPs) family; its overexpression has been widely demonstrated to occur in various types of cancer. Overexpression of survivin also correlates with tumor progression and induces anticancer drug resistance. Interestingly, recent studies reveal that survivin exhibits multiple pro-mitotic and anti-apoptotic functions; the differential functions of survivin seem to be caused by differential subcellular localization, phosphorylation, and acetylation of this molecule. In this review, the complex expression regulations and post-translational modifications of survivin are discussed. This review also discusses how recent discoveries improve our understanding of survivin biology and also create opportunities for developing differential-functioned survivin-targeted therapy. Databases such as PubMed, Scopus® (Elsevier, New York, NY, USA), and SciFinder® (CAS, Columbus, OH, USA) were used to search for literature in the preparation of this review. Keywords: survivin, BIRC5, IAP, XIAP, caspase-9, Samc, DIABLO
Matching Content Categories {๐}
- Education
- Politics
- Careers
Content Management System {๐}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {๐}
What is the average monthly size of doi.org audience?
๐ Strong Traffic: 100k - 200k visitors per month
Based on our best estimate, this website will receive around 100,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {๐ธ}
We're unsure if the website is profiting.
Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.
Keywords {๐}
medical, press, survivin, review, dove, cheng, national, tainan, authors, medicine, work, open, published, learn, huang, chang, kung, university, terms, informa, center, reprints, access, research, journals, peer, oncology, permission, article, department, college, division, plc, contact, testimonials, favored, author, login, search, scientific, papers, manuscript, member, therapy, volume, biology, cheung, tsai, lee, chen,
Topics {โ๏ธ}
chi-mei medical center including fast-track processing dove medical press manuscript login 1 yi-chun huang favored authors specific author basic medical sciences differential subcellular localization search offer real benefits 5 jang-yang chang3 recent studies reveal complex expression regulations post-translational modifications recent discoveries improve author academic publishing division london sw1p 1wg uk vat group 3 fang-ying tsai 2 yung-chieh chang anti-apoptotic functions papers 1 shang-hung chen articles published informa plc 2 chien-chang huang differential functions medical journals survivin biology published cheng sm review lee jy full terms cancer research journals ยป oncotargets scientific journal alerts pharmaceutical industry therapeutic target s33374 checked 3national institute china abstract apoptosis proteins widely demonstrated tumor progression create opportunities properly attributed
Questions {โ}
- Why publish with us?
Social Networks {๐}(9)
- https://www.facebook.com/DoveMedicalPress
- https://twitter.com/DovePress
- https://www.linkedin.com/company/dove-medical-press
- https://www.youtube.com/user/dovepress
- https://www.instagram.com/dovemedicalpress/
- https://twitter.com/intent/tweet?text=Survivin+%26ndash%3B+biology+and+potential+as+a+therapeutic+target+in+onco+%7C+OTT+%40DovePress&related=DovePress&url=https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT
- https://www.facebook.com/sharer.php?u=https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT&t=Survivin โ biology and potential as a therapeutic target in onco | OTT
- https://www.linkedin.com/shareArticle?mini=true&url=https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT&title=Survivin โ biology and potential as a therapeutic target in onco | OTT&source=Dove Press
- https://www.reddit.com/submit?url=https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT
External Links {๐}(56)
- https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/browse_journals.php's financial summary
- How much profit does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/about-us make?
- What is the earnings of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/editorial-policies?
- How much does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/author-guidelines generate monthly?
- What's the total monthly financial gain of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/peer-review-guidelines?
- Revenue of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/open_outlook.php
- What's the financial intake of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/browse_hot_topics.php?
- How much profit is https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/podcasts making per month?
- Explore the financials of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/blog
- Financial intake of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/bulk_reprints.php
- What's the financial gain of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/submit_step_1.php?
- How much revenue does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/# generate?
- https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/contact's financial summary
- What's https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/sustainability.php's gross income?
- Explore the financials of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/press-releases
- How much does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/why-publish-with-dove-press/testimonials bring in each month?
- Income figures for https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/why-publish-with-dove-press/favored-authors
- How much does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/permissions.php gross monthly?
- https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/presubmission_check.php's total income per month
- How much money does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/login.php generate?
- What are the total earnings of http://www.dovepress.com.cn?
- What's the income of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/index.php?
- Check the income stats for https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/search_advance.php
- What's the financial gain of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/editorial_policies.php?
- Discover the revenue of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/script_status.php
- What are the earnings of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/register.php?
- Discover the revenue of https://www.dovepress.com/about_dovepress.php
- Monthly income for https://www.dovepress.com/why-publish-with-dove-press/open-access/
- How much cash flow does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/fav_author.php have monthly?
- What's the financial intake of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/oncotargets-and-therapy-journal?
- How much does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/oncotargets-and-therapy-archive23-v646 bring in each month?
- What's the revenue for https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/qr.php?p=https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT?
- How much money does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/mailto:?subject=Open Access article on Dove Medical Press&body=Check out this article: https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT generate?
- How much does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/article_metric.php?article_id=14692 generate monthly?
- What's the monthly income of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/get_permissions.php?a_id=14692?
- Check the income stats for https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/author_profile.php?id=329670
- How much does https://orcid.org/0000-0003-4181-1435 make?
- What's the financial intake of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/author_profile.php?id=329671?
- How much revenue does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/author_profile.php?id=329672 generate?
- How much does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/author_profile.php?id=329673 make?
- Monthly income for https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/author_profile.php?id=329674
- Earnings of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/author_profile.php?id=329675
- How much does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/author_profile.php?id=329676 earn?
- Find out how much https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/author_profile.php?id=340620 earns monthly
- How much does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/author_profile.php?id=162040 bring in each month?
- Profit of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/article/download/14692
- How much does https://www.dovepress.com/terms.php make?
- How much revenue does https://creativecommons.org/licenses/by-nc/3.0/ produce monthly?
- What's https://www.informa.com/privacy-policy/'s gross income?
- How much money does https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/partners.php generate?
- Find out how much https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/terms.php earns monthly
- How much income is https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/cookies.php earning monthly?
- Discover the revenue of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/#page-top
- What is the monthly revenue of https://www.dovepress.com/survivin-ndash-biology-and-potential-as-a-therapeutic-target-in-oncolo-peer-reviewed-fulltext-article-OTT/privacy.php?
- https://phplab.nz/'s financial summary
- How much money does https://www.adhesion.co.nz make?
Analytics and Tracking {๐}
- Google Analytics
- Google Tag Manager
- Google Universal Analytics
Libraries {๐}
- jQuery
Emails and Hosting {โ๏ธ}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {๐ฆ}
- Com/cm/ef49a3f1-d8c1-47d6-88fc-50e41130631f/airgap